CISPLATIN
Active substance: cisplatin
INJECTION, SOLUTION · CISPLATIN 1 mg/mL
United StatesActive
Marketing holder: Gland Pharma Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- CISPLATIN · 1 mg/mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 24 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3f6c-7b5f-991e-cadfe6fb09fe,01a120c3-41d6-7673-88d3-75556115bd57,01a120c3-5123-783a-ae36-abcea1c85a57,01a120c3-9052-71c5-9724-7e47b418d415,01a120c4-b946-7793-aaac-10eca52ba56b;count=16 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-a079-701e-bc39-8adbe21aadc4,01a1208c-a402-75ab-b65b-fc9bb4a5ad9c,01a1208d-1482-7e4f-8fae-f578514a3d13,01a1208e-b76e-7a68-b279-316d8029f39e,01a1208f-03f9-71e9-8022-33360105ddb2;count=19 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 68083-162
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
- product · openFDA NDC · 68083-162 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68083-162 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68083-162 · Verified 2026-10-09 · open in source